View in EDS

Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.

Saved in:
Bibliographic Details
Title: Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
Authors: Moore, M.1 malcolm.moore@bccancer.bc.ca, Gill, S.1, Asmis, T.2, Berry, S.3, Burkes, R.4, Zbuk, K.5, Alcindor, T.6, Jeyakumar, A.7, Chan, T.8, Rao, S.9, Spratlin, J.10, Tang, P. A.11, Rothenstein, J.12, Chan, E.13, Bendell, J.14, Kudrik, F.15, Kauh, J.16, Tang, S.16, Gao, L.16, Kambhampati, S. R. P.16
Source: Annals of Oncology. Dec2016, Vol. 27 Issue 12, p2216-2224. 9p. 2 Diagrams, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 120429433
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Moore%2C+M%2E%22">Moore, M.</searchLink><relatesTo>1</relatesTo><i> malcolm.moore@bccancer.bc.ca</i><br /><searchLink fieldCode="AR" term="%22Gill%2C+S%2E%22">Gill, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Asmis%2C+T%2E%22">Asmis, T.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Berry%2C+S%2E%22">Berry, S.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Burkes%2C+R%2E%22">Burkes, R.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Zbuk%2C+K%2E%22">Zbuk, K.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Alcindor%2C+T%2E%22">Alcindor, T.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Jeyakumar%2C+A%2E%22">Jeyakumar, A.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Chan%2C+T%2E%22">Chan, T.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Rao%2C+S%2E%22">Rao, S.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Spratlin%2C+J%2E%22">Spratlin, J.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Tang%2C+P%2E+A%2E%22">Tang, P. A.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Rothenstein%2C+J%2E%22">Rothenstein, J.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Chan%2C+E%2E%22">Chan, E.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Bendell%2C+J%2E%22">Bendell, J.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Kudrik%2C+F%2E%22">Kudrik, F.</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Kauh%2C+J%2E%22">Kauh, J.</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Tang%2C+S%2E%22">Tang, S.</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Gao%2C+L%2E%22">Gao, L.</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Kambhampati%2C+S%2E+R%2E+P%2E%22">Kambhampati, S. R. P.</searchLink><relatesTo>16</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Dec2016, Vol. 27 Issue 12, p2216-2224. 9p. 2 Diagrams, 3 Charts, 1 Graph.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=120429433
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdw412
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 2216
    Titles:
      – TitleFull: Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moore, M.
      – PersonEntity:
          Name:
            NameFull: Gill, S.
      – PersonEntity:
          Name:
            NameFull: Asmis, T.
      – PersonEntity:
          Name:
            NameFull: Berry, S.
      – PersonEntity:
          Name:
            NameFull: Burkes, R.
      – PersonEntity:
          Name:
            NameFull: Zbuk, K.
      – PersonEntity:
          Name:
            NameFull: Alcindor, T.
      – PersonEntity:
          Name:
            NameFull: Jeyakumar, A.
      – PersonEntity:
          Name:
            NameFull: Chan, T.
      – PersonEntity:
          Name:
            NameFull: Rao, S.
      – PersonEntity:
          Name:
            NameFull: Spratlin, J.
      – PersonEntity:
          Name:
            NameFull: Tang, P. A.
      – PersonEntity:
          Name:
            NameFull: Rothenstein, J.
      – PersonEntity:
          Name:
            NameFull: Chan, E.
      – PersonEntity:
          Name:
            NameFull: Bendell, J.
      – PersonEntity:
          Name:
            NameFull: Kudrik, F.
      – PersonEntity:
          Name:
            NameFull: Kauh, J.
      – PersonEntity:
          Name:
            NameFull: Tang, S.
      – PersonEntity:
          Name:
            NameFull: Gao, L.
      – PersonEntity:
          Name:
            NameFull: Kambhampati, S. R. P.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1